1887
  1. Home
  2. Eurosurveillance
  3. Volume 30, Issue 11, 20/Mar/2025
  4. Article
Rapid communication Open Access
Like 0
Download

SDG 3: Tuberculosis

Abstract

We observed shifting trends in tuberculosis (TB) epidemiology in the EU/EEA between 2019 and 2023. In 2023, TB notifications among people of foreign origin increased by 24.6% after decreasing between 2019 and 2020. The majority originated from African and East Mediterranean regions, with a 316.4% upsurge in TB among Ukrainians in 2022–23. Rifampicin-resistant/multidrug-resistant TB increased by ≥ 60% in 2019–23, mainly among Ukrainians. Rapid response to shifting epidemiological patterns is crucial for efficient TB prevention and control within the EU/EEA.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.11.2500173
2025-03-20
2025-03-22
/content/10.2807/1560-7917.ES.2025.30.11.2500173
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/11/eurosurv-30-11-2.html?itemId=/content/10.2807/1560-7917.ES.2025.30.11.2500173&mimeType=html&fmt=ahah

References

  1. Eurostat. Migration and asylum in Europe – 2024 edition. Brussels: European Commission Publications Office; 2024. Available from: https://data.europa.eu/doi/10.2785/43971
  2. International Organization for Migration (IOM). World Migration Report 2024. Geneva: IOM; 2024. Available from: https://publications.iom.int/books/world-migration-report-2024
  3. Stoycheva K, Cristea V, Ködmön C, Rosales-Klintz S, Zenner D, Vasiliu A, et al. Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022. Euro Surveill. 2024;29(12):2400094.  https://doi.org/10.2807/1560-7917.ES.2024.29.12.2400094  PMID: 38516786 
  4. World Health Organization (WHO). WHO regional offices. Geneva: WHO. [Accessed: 19 Feb 2025]. Available from: https://www.who.int/about/who-we-are/regional-offices
  5. United Nations Statistics Division (UNSD). Methodology - Standard country or area codes for statistical use (M49). New York: UNSD. [Accessed: 19 Feb 2025]. Available from: https://unstats.un.org/unsd/methodology/m49
  6. Falzon D, Zignol M, Bastard M, Floyd K, Kasaeva T. The impact of the COVID-19 pandemic on the global tuberculosis epidemic. Front Immunol. 2023;14:1234785.  https://doi.org/10.3389/fimmu.2023.1234785  PMID: 37795102 
  7. McQuaid CF, Vassall A, Cohen T, Fiekert K, White RG, COVID/TB Modelling Working Group. The impact of COVID-19 on TB: a review of the data. Int J Tuberc Lung Dis. 2021;25(6):436-46.  https://doi.org/10.5588/ijtld.21.0148  PMID: 34049605 
  8. World Health Organization (WHO). WHO operational handbook on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Geneva: WHO; 2022. Available from: https://www.who.int/publications/i/item/9789240063129
  9. World Health Organization. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27-29 October 2020. Geneva: WHO; 2021. Available from: https://iris.who.int/handle/10665/338776
  10. European Council (EC). Refugees from Ukraine in the EU. Consilium. Brussels: EC. [Accessed: 20 Feb 2025]. Available from: https://www.consilium.europa.eu/en/infographics/ukraine-refugees-eu
  11. Ködmön C, Zucs P, van der Werf MJ. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013. Euro Surveill. 2016;21(12):30164.  https://doi.org/10.2807/1560-7917.ES.2016.21.12.30164  PMID: 27039665 
  12. Günther G, Guglielmetti L, Leu C, van Leth F, Lange C. Relative cost of multidrug-resistant TB medicines in Europe. Int J Tuberc Lung Dis. 2023;27(5):341-4.  https://doi.org/10.5588/ijtld.23.0026  PMID: 37143231 
  13. Maurer FP, Shubladze N, Kalmambetova G, Felker I, Kuchukhidze G, Köser CU, et al. Diagnostic capacities for multidrug-resistant tuberculosis in the World Health Organization European Region: action is needed by all Member States. J Mol Diagn. 2022;24(11):1189-94.  https://doi.org/10.1016/j.jmoldx.2022.07.005  PMID: 35964846 
Shifting tuberculosis dynamics in the EU/EEA: geographical and drug resistance trends among people of foreign origin, 2019 to 2023
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Anca+Vasiliu&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vasiliu Anca</a>, <a href="/search?value1=Veronica+Cristea&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Cristea Veronica</a>, <a href="/search?value1=Krista+Stoycheva&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stoycheva Krista</a>, <a href="/search?value1=Senia+Rosales-Klintz&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rosales-Klintz Senia</a>, <a href="/search?value1=Christoph+Lange&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lange Christoph</a>, <a href="/search?value1=Dominik+Zenner&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zenner Dominik</a>, <a href="/search?value1=Csaba+K%C3%B6dm%C3%B6n&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ködmön Csaba</a></span>. Shifting tuberculosis dynamics in the EU/EEA: geographical and drug resistance trends among people of foreign origin, 2019 to 2023. <a href="/content/ecdc">Euro Surveill.</a> 2025;30(11):pii=2500173. <a href="https://doi.org/10.2807/1560-7917.ES.2025.30.11.2500173" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2025.30.11.2500173</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 12 Mar 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 19 Mar 2025 </span> </p>
/content/10.2807/1560-7917.ES.2025.30.11.2500173
/content/10.2807/1560-7917.ES.2025.30.11.2500173
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error